Preliminary efficacy and safety of Relmacabtagene autoleucel (Carteyva) in adults with relapsed/refractory follicular lymphoma in China: A phase I/II clinical trial

被引：2

作者：

Ying, Zhitao ^{[1
]}

Zou, Dehui ^{[2
,3
]}

Yang, Haiyan ^{[4
]}

Wu, Jianqiu ^{[5
]}

Guo, Ye ^{[6
]}

Li, Wenyu ^{[7
]}

Liu, Hui ^{[8
]}

Wang, Chris ^{[9
]}

Ma, Laura ^{[9
]}

Yang, Su ^{[9
]}

Zhou, Zisong ^{[9
]}

Qin, Yun ^{[9
]}

Song, Yuqin ^{[1
]}

Zhu, Jun ^{[1
]}

机构：

[1] Peking Univ Canc Hosp & Inst, Dept Lymphoma, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, 52 Fucheng Rd, Beijing 100142, Peoples R China

[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Dept Lymphoma & Myeloma, Tianjin, Peoples R China

[3] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin, Peoples R China

[4] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Chinese Acad Sci, Canc Hosp,Inst Basic Med & Canc IBMC,Dept Lymphom, Hangzhou, Zhejiang, Peoples R China

[5] Nanjing Med Univ, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Jiangsu Red Cross Canc Ctr,Dept Med Oncol, Nanjing, Peoples R China

[6] Tongji Univ, Shanghai Dongfang Hosp, Dept Oncol, Shanghai, Peoples R China

[7] Guangdong Acad Sci, Guangdong Prov Peoples Hosp, Dept Lymphoma, Guangzhou, Guangdong, Peoples R China

[8] Beijing Hosp, Dept Hematol, Beijing, Peoples R China

[9] JW Therapeut Shanghai Co Ltd, Shanghai, Peoples R China

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2022年 / 97卷 / 12期

关键词：

D O I：

10.1002/ajh.26711

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E436 / E438

页数：3

共 50 条

[21] Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
Chen, Robert
Zinzani, Pier Luigi
Fanale, Michelle A.
Armand, Philippe
Johnson, Nathalie A.
Brice, Pauline
Radford, John
Ribrag, Vincent
Molin, Daniel
Vassilakopoulos, Theodoros P.
Tomita, Akihiro
von Tresckow, Bastian
Shipp, Margaret A.
Zhang, Yinghua
Ricart, Alejandro D.
Balakumaran, Arun
Moskowitz, Craig H.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) : 2125 - +
[22] Phase I Safety and Preliminary Efficacy of Acalabrutinib, Venetoclax, and Obinutuzumab (AVO) in Patients with Relapsed/Refractory Mantle Cell Lymphoma
Kim, Austin I.
Armand, Philippe
Redd, Robert A.
Forsyth, Megan
Branch, Paul
Pazienza, Samantha
Brennan, Lisa
Patterson, Victoria
Waisgerber, Susan M.
Merryman, Reid W.
Fisher, David C.
Ryan, Christine E.
Ahn, Inhye E.
Crombie, Jennifer L.
Odejide, Oreofe O.
LaCasce, Ann
Jacobson, Caron A.
Jacobsen, Eric
Parry, Erin M.
Davids, Matthew S.
Brown, Jennifer R.
Freedman, Arnold S.
Riedell, Peter A.
Murakami, Mark Alan
BLOOD, 2023, 142
[23] Efficacy and safety of bendamustine plus bortezomib in relapsed/refractory multiple myeloma: A phase I/II trial.
Berenson, J. R.
Yellin, O.
Bessudo, A.
Boccia, R.
Noga, S.
Gravenor, D.
Patel-Donnelly, D.
Siegel, R. S.
Kewalramani, T.
Gorak, E. J.
Swift, R.
Bensen-Kennedy, D.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[24] Relmacabtagene autoleucel (relma-cel) CD19 CAR-T therapy for adults with heavily pretreated relapsed/refractory large B-cell lymphoma in China
Ying, Zhitao
Yang, Haiyan
Guo, Ye
Li, Wenyu
Zou, Dehui
Zhou, Daobin
Wang, Zhao
Zhang, Mingzhi
Wu, Jianqiu
Liu, Hui
Zhang, Pian
Yang, Su
Zhou, Zisong
Zheng, Hongxia
Song, Yuqin
Zhu, Jun
CANCER MEDICINE, 2021, 10 (03): : 999 - 1011
[25] Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
Nathan Hale Fowler
Michael Dickinson
Martin Dreyling
Joaquin Martinez-Lopez
Arne Kolstad
Jason Butler
Monalisa Ghosh
Leslie Popplewell
Julio C. Chavez
Emmanuel Bachy
Koji Kato
Hideo Harigae
Marie José Kersten
Charalambos Andreadis
Peter A. Riedell
P. Joy Ho
José Antonio Pérez-Simón
Andy I. Chen
Loretta J. Nastoupil
Bastian von Tresckow
Andrés José María Ferreri
Takanori Teshima
Piers E. M. Patten
Joseph P. McGuirk
Andreas L. Petzer
Fritz Offner
Andreas Viardot
Pier Luigi Zinzani
Ram Malladi
Aiesha Zia
Rakesh Awasthi
Aisha Masood
Oezlem Anak
Stephen J. Schuster
Catherine Thieblemont
Nature Medicine, 2022, 28 : 325 - 332
[26] Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
Fowler, Nathan Hale
Dickinson, Michael
Dreyling, Martin
Martinez-Lopez, Joaquin
Kolstad, Arne
Butler, Jason
Ghosh, Monalisa
Popplewell, Leslie
Chavez, Julio C.
Bachy, Emmanuel
Kato, Koji
Harigae, Hideo
Kersten, Marie Jose
Andreadis, Charalambos
Riedell, Peter A.
Ho, P. Joy
Perez-Simon, Jose Antonio
Chen, Andy, I
Nastoupil, Loretta J.
von Tresckow, Bastian
Ferreri, Andres Jose Maria
Teshima, Takanori
Patten, Piers E. M.
McGuirk, Joseph P.
Petzer, Andreas L.
Offner, Fritz
Viardot, Andreas
Zinzani, Pier Luigi
Malladi, Ram
Zia, Aiesha
Awasthi, Rakesh
Masood, Aisha
Anak, Oezlem
Schuster, Stephen J.
Thieblemont, Catherine
NATURE MEDICINE, 2022, 28 (02) : 325 - +
[27] Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma
Armand, Philippe
Janssens, Ann
Gritti, Giuseppe
Radford, John
Timmerman, John
Pinto, Antonio
Vilchez, Santiago Mercadal
Johnson, Peter
Cunningham, David
Leonard, John P.
Rodig, Scott J.
Martin-Regueira, Patricia
Sumbul, Anne
Samakoglu, Selda
Tang, Hao
Ansell, Stephen M.
BLOOD, 2021, 137 (05) : 637 - 645
[28] A Phase II Study of Brentuximab Vedotin and Bendamustine for Relapsed/Refractory Follicular Lymphoma
Kaleka, Guneet
Moskoff, Benjamin
Zafar, Aneeqa
Esteghamat, Naseem S.
Abedi, Mehrdad
Socola, Francisco Andres
Hoeg, Rasmus T.
Tuscano, Joseph M.
BLOOD, 2024, 144 : 6318 - 6319
[29] Systematic Literature Review of the Clinical Efficacy and Safety of Treatments in the Relapsed/Refractory Setting for Patients with Follicular Lymphoma or Marginal Zone Lymphoma
Monga, Neerav
Garside, Jamie
O'Donovan, Peter
Quigley, Joan
Padhiar, Amie
Parisi, Lori
Tapprich, Christoph
Nastoupil, Loretta
BLOOD, 2017, 130
[30] Primary Analysis of the Phase 2 ELARA Trial: Tisagenlecleucel Efficacy and Safety in Adult Patients with Relapsed/Refractory Follicular Lymphoma (r/r FL)
Schuster, Stephen J.
Dickinson, Michael
Dreyling, Martin
Martinez-Lopez, Joaquin
Kolstad, Arne
Butler, Jason
Ghosh, Monalisa
Popplewell, Leslie
Chavez, Julio C.
Bachy, Emmanuel
Kato, Koji
Harigae, Hideo
Kersten, Marie Jose
Andreadis, Charalambos
Riedell, Peter
Zia, Aiesha
Morisse, Mony Chenda
Fowler, Nathan Hale
Thieblemont, Catherine
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S403 - S404

← 1 2 3 4 5 →